Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Chembio Diagnostics, Inc (NASDAQ: CEMI).

Full DD Report for CEMI

You must become a subscriber to view this report.


Recent News from (NASDAQ: CEMI)

Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors
MEDFORD, N.Y., May 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that John Potthoff, Ph.D., has been appointed to its Board of Directors.  Dr. Potthoff has 25 ...
Source: GlobeNewswire
Date: May, 16 2018 08:00
Chembio Diagnostics' (CEMI) CEO John Sperzel on Q1 2018 Results - Earnings Call Transcript
Chembio Diagnostics, Inc. (CEMI) Q1 2018 Earnings Conference Call May 9, 2018 16:30 ET Executives John Sperzel - President and CEO Neil Goldman - Executive VP and CFO Analysts Per Ostlund - Craig-Hallum Ray Myers - The Benchmark Company Brian Marckx - Zacks Investment Res...
Source: SeekingAlpha
Date: May, 12 2018 07:48
Chembio Diagnostics beats by $0.09, beats on revenue
Chembio Diagnostics (NASDAQ: CEMI ): Q1 EPS of -$0.05 beats by $0.09 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 09 2018 16:33
Chembio Diagnostics Reports First Quarter 2018 Financial Results
MEDFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the first quarter ended March 31, 2018. Recent Accomplishments & Highlights Ac...
Source: GlobeNewswire
Date: May, 09 2018 16:11
Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018
MEDFORD, N.Y., April 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the first quarter 2018 after the close of trading on Wednesday, May 9, 20...
Source: GlobeNewswire
Date: April, 26 2018 16:05
Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
MEDFORD, N.Y., April 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a collaboration agreement with LumiraDx to develop new POC diagnostic tests...
Source: GlobeNewswire
Date: April, 25 2018 08:00
Chembio Diagnostics' (CEMI) CEO John Sperzel on Q4 2017 Results - Earnings Call Transcript
Chembio Diagnostics, Inc. (CEMI) Q4 2017 Results Earnings Conference Call March 8, 2018, 04:30 PM ET Executives Lynn Lewis - IR John Sperzel - Chief Executive Officer Neil Goldman - CPA, EVP and CFO Analysts Kevin Ellich - Craig-Hallum Capital Raymond Myers - The Benchmar...
Source: SeekingAlpha
Date: March, 09 2018 00:16
Chembio Diagnostics misses by $0.06, beats on revenue
Chembio Diagnostics (NASDAQ: CEMI ): Q4 EPS of -$0.16 misses by $0.06 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 08 2018 16:16
Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
MEDFORD, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2017. Recent Accomplishments &a...
Source: GlobeNewswire
Date: March, 08 2018 16:05
Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018
MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2017 after the close of trading on Thursd...
Source: GlobeNewswire
Date: February, 22 2018 17:58

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-0111.3511.5011.5011.3531,007
2018-07-3111.3011.3511.3511.2521,430
2018-07-3011.4011.3011.4011.2535,156
2018-07-2711.1511.2511.2611.155,639
2018-07-2611.22111.2511.2511.212,104

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-217212,71126.5954Cover
2018-08-206013,32118.0970Cover
2018-08-171,5002,30165.1890Short
2018-08-1611100.0000Short
2018-08-157002,55427.4080Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CEMI.


About Chembio Diagnostics, Inc (NASDAQ: CEMI)

Logo for Chembio Diagnostics, Inc (NASDAQ: CEMI)

Not available

 

Contact Information

 

 

Current Management

  • Lawrence A. Siebert / President, CEO
  • Richard J. Larkin / CFO
  • Susan Norcott / IR
  • Katherine L. Davis /
  • Barbara DeBuono /
  • Peter Kissinger /
  • Gary Meller /
  • Lawrence A. Siebert /

Current Share Structure

  • Market Cap: $123,923,643 - 05/15/2018
  • Issue and Outstanding: 14,162,702 - 03/05/2018

 


Recent Filings from (NASDAQ: CEMI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018

 

 


Daily Technical Chart for (NASDAQ: CEMI)

Daily Technical Chart for (NASDAQ: CEMI)


Stay tuned for daily updates and more on (NASDAQ: CEMI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CEMI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CEMI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CEMI and does not buy, sell, or trade any shares of CEMI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/